What is Beacon Pharmaceuticals Price-to-Operating-Cash-Flow?
As of today (2024-04-25), Beacon Pharmaceuticals's share price is BDT195.70.
Beacon Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT-1.20. Hence, Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 8 years, Beacon Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 288.81. The lowest was 48.17. And the median was 105.33.
Beacon Pharmaceuticals's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was BDT-2.99.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was BDT-1.20.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Beacon Pharmaceuticals was -141.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.70% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 25.80% per year.
During the past 8 years, Beacon Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 70.00% per year. The lowest was -33.30% per year. And the median was -13.10% per year.
Beacon Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beacon Pharmaceuticals Price-to-Operating-Cash-Flow Chart
|
Beacon Pharmaceuticals Annual Data
|
|
Trend |
Jun16 |
Jun17 |
Jun18 |
Jun19 |
Jun20 |
Jun21 |
Jun22 |
Jun23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
21.07 |
48.17 |
145.24 |
55.13 |
91.11 |
|
Beacon Pharmaceuticals Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
98.52 |
111.13 |
91.11 |
82.83 |
- |
Competitive Comparison of Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Beacon Pharmaceuticals Price-to-Operating-Cash-Flow Calculation
Beacon Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 195.70 | / | -1.197 |
| = | |
Beacon Pharmaceuticals's Share Price of today is BDT195.70.
Beacon Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-1.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Beacon Pharmaceuticals (DHA:BEACONPHAR) Business Description
Traded in Other Exchanges
N/A
Address
9/B/2, Toyenbee Circular Road, Motijheel C/A, Beacon Business Centre, Dhaka, BGD, 1223
Beacon Pharmaceuticals PLC manufactures and markets pharmaceutical products. Its products are used in various therapeutic areas, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, and muscle relaxants. The company exports its products to Europe, America, Australia, Africa, and Asia. The company's products can be segmented as General, Chronic Care, Oncology, and Biotech products.
Beacon Pharmaceuticals (DHA:BEACONPHAR) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:BEACONPHAR has been successfully added to your